These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 38305340)

  • 1. A Path of Novelty from Nanoparticles to Nanobots: Theragnostic Approach for Targeting Cancer Therapy.
    Kaur G; Khanna B; Yusuf M; Sharma A; Khajuria A; Alajangi HK; Jaiswal PK; Sachdeva M; Barnwal RP; Singh G
    Crit Rev Ther Drug Carrier Syst; 2024; 41(4):1-38. PubMed ID: 38305340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detecting and destroying cancer cells in more than one way with noble metals and different confinement properties on the nanoscale.
    Dreaden EC; El-Sayed MA
    Acc Chem Res; 2012 Nov; 45(11):1854-65. PubMed ID: 22546051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic and diagnostic applications of nanoparticles.
    Youns M; Hoheisel JD; Efferth T
    Curr Drug Targets; 2011 Mar; 12(3):357-65. PubMed ID: 20955146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoparticles in oncology: the new theragnostic molecules.
    Allegra A; Penna G; Alonci A; Rizzo V; Russo S; Musolino C
    Anticancer Agents Med Chem; 2011 Sep; 11(7):669-86. PubMed ID: 21787275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances of medical nanorobots for future cancer treatments.
    Kong X; Gao P; Wang J; Fang Y; Hwang KC
    J Hematol Oncol; 2023 Jul; 16(1):74. PubMed ID: 37452423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inorganic Nanoparticles for Cancer Therapy: A Transition from Lab to Clinic.
    Bayda S; Hadla M; Palazzolo S; Riello P; Corona G; Toffoli G; Rizzolio F
    Curr Med Chem; 2018; 25(34):4269-4303. PubMed ID: 29284391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theragnostic potentials of core/shell mesoporous silica nanostructures.
    Ravindran Girija A; Balasubramanian S
    Nanotheranostics; 2019; 3(1):1-40. PubMed ID: 30662821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticles Mediated Target-specific Drug Delivery in Prostate Cancer: An In-depth Review.
    Upadhyay TK; Ali MI; Khan F; Goel H; Mathur M; Goyal K; Moin S; Pandey P; Tanwar P; Sharangi AB; Gautam SDC; Kapdi JK; Patel KI; Patel MV; Parmar AM; Kamal MA
    Curr Med Chem; 2022; 29(24):4170-4184. PubMed ID: 34939536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Review of Multifunction Smart Nanoparticle based Drug Delivery Systems.
    Fatima H; Naz MY; Shukrullah S; Aslam H; Ullah S; Assiri MA
    Curr Pharm Des; 2022; 28(36):2965-2983. PubMed ID: 35466867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Review on Recent Technologies and Patents on Silica Nanoparticles for Cancer Treatment and Diagnosis.
    Gupta A; Kushwaha SS; Mishra A
    Recent Pat Drug Deliv Formul; 2020; 14(2):126-144. PubMed ID: 32928094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent update of toxicity aspects of nanoparticulate systems for drug delivery.
    Patnaik S; Gorain B; Padhi S; Choudhury H; Gabr GA; Md S; Kumar Mishra D; Kesharwani P
    Eur J Pharm Biopharm; 2021 Apr; 161():100-119. PubMed ID: 33639254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanomedicines Targeting the Tumor Microenvironment.
    Tong R; Langer R
    Cancer J; 2015; 21(4):314-21. PubMed ID: 26222084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug delivery nanoparticles in skin cancers.
    Dianzani C; Zara GP; Maina G; Pettazzoni P; Pizzimenti S; Rossi F; Gigliotti CL; Ciamporcero ES; Daga M; Barrera G
    Biomed Res Int; 2014; 2014():895986. PubMed ID: 25101298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous stimuli-responsive nanoparticles for cancer therapy: From bench to bedside.
    Xie F; Wang M; Chen Q; Chi T; Zhu S; Wei P; Yang Y; Zhang L; Li X; Liao Z
    Pharmacol Res; 2022 Dec; 186():106522. PubMed ID: 36283629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific targeting cancer cells with nanoparticles and drug delivery in cancer therapy.
    Raj S; Khurana S; Choudhari R; Kesari KK; Kamal MA; Garg N; Ruokolainen J; Das BC; Kumar D
    Semin Cancer Biol; 2021 Feb; 69():166-177. PubMed ID: 31715247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting cancer cells with nanotherapeutics and nanodiagnostics: Current status and future perspectives.
    Ali ES; Sharker SM; Islam MT; Khan IN; Shaw S; Rahman MA; Uddin SJ; Shill MC; Rehman S; Das N; Ahmad S; Shilpi JA; Tripathi S; Mishra SK; Mubarak MS
    Semin Cancer Biol; 2021 Feb; 69():52-68. PubMed ID: 32014609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
    Shapira A; Livney YD; Broxterman HJ; Assaraf YG
    Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances of polymeric nanoplatforms for cancer treatment: smart delivery systems (SDS), nanotheranostics and multidrug resistance (MDR) inhibition.
    Gupta U; Maity D; Sharma VK
    Biomed Mater; 2023 Nov; 19(1):. PubMed ID: 37944188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasound-mediated nano drug delivery for treating cancer: Fundamental physics to future directions.
    Moradi Kashkooli F; Jakhmola A; Hornsby TK; Tavakkoli JJ; Kolios MC
    J Control Release; 2023 Mar; 355():552-578. PubMed ID: 36773959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.